Amneal Pharmaceuticals Llc NJ Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Amneal Pharmaceuticals Llc NJ Pharmaceutical Import Records from India — 4 Products, $1.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Amneal Pharmaceuticals Llc NJ — Pharmaceutical Importer Profile (2026) | 4 Products, $1.1M Trade | TransData Nexus

Amneal Pharmaceuticals Llc NJ

Pharmaceutical Importer · United States · Advanced Antibiotics Focus · $1.1M Total Trade · DGFT Verified

Amneal Pharmaceuticals Llc NJ is a pharmaceutical importer based in United States with a total trade value of $1.1M across 4 products in 3 therapeutic categories. Based on 23 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Amneal Pharmaceuticals Llc NJ sources from 1 verified Indian supplier, with Amneal Pharmaceuticals Private Limited accounting for 100.0% of imports.

Amneal Pharmaceuticals Llc NJ — Import Portfolio & Supplier Network

Amneal Pharmaceuticals Llc NJ import network — 4 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Amneal Pharmaceuticals Llc NJ?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Amneal Pharmaceuticals Private Limited	$2.4M	55	100.0%

Amneal Pharmaceuticals Llc NJ sources from 1 verified Indian supplier across 32 distinct formulations. The sourcing is highly concentrated — Amneal Pharmaceuticals Private Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Ibuprofen tablets USP 800MG 500	$280.6K	6
Sulfamethoxazole and	$239.6K	5
Propranolol hydrochloridetablets	$200.0K	4
Propranolol hydrochloridetablets	$200.0K	4
Tramadol hydrochloride	$100.0K	2
Folic acid tablets, USP 1 MG 1000	$100.0K	2
Primidone tablets USP 50 MG 500	$100.0K	2
Tramadol hydrochloride	$100.0K	2
Memantine hydrochloridetablets	$63.2K	2
Primidone tablets, USP 50 MG	$50.0K	1
Raloxifene hcl tablets,usp60mg	$50.0K	1
Dried granules for entecavirtablets	$50.0K	1
Gabapentin capsules,USP 100 MG 500	$50.0K	1
Primidone tablets, USP 50 MG 500	$50.0K	1
Primidone tablets, USP 250 MG 100	$50.0K	1

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Propranolol	Cardiovascular	$400.0K	8	0.7%	3
2	Sulfamethoxazole	Advanced Antibiotics	$250.0K	5	1.3%	4
3	Tramadol	Analgesics & Antipyretics	$250.0K	5	0.1%	16
4	Trimethoprim	Advanced Antibiotics	$250.0K	5	0.9%	4

Amneal Pharmaceuticals Llc NJ imports 4 pharmaceutical products across 3 categories into United States totaling $1.1M.

Amneal Pharmaceuticals Llc NJ — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Amneal Pharmaceuticals LLC, headquartered in Bridgewater, New Jersey, is a prominent player in the U.S. pharmaceutical industry, specializing in the development, manufacturing, and distribution of generic and specialty pharmaceutical products. Established in 2002, the company has grown into one of the largest generic drug manufacturers in the United States. Amneal's diverse portfolio encompasses over 280 product families, including complex generics, injectables, biosimilars, and specialty brands targeting central nervous system and endocrine disorders.

In 2018, Amneal Pharmaceuticals LLC merged with Impax Laboratories, Inc., forming Amneal Pharmaceuticals, Inc. This strategic consolidation expanded Amneal's capabilities and market presence, positioning it as a significant entity in the pharmaceutical sector. The company's operations span North America, Asia, and Europe, with manufacturing facilities in New Jersey, New York, India, and Ireland, and distribution centers in Kentucky.

2Distribution Network

Amneal Pharmaceuticals LLC's distribution network is strategically designed to ensure efficient delivery of its products across the United States and internationally. The company operates a consolidated distribution and sales logistics center in Glasgow, Kentucky, which serves as a hub for its U.S. operations. This facility supports the distribution of a wide range of pharmaceutical products to meet the needs of various stakeholders, including healthcare providers, pharmacies, and government agencies.

Internationally, Amneal has established a significant presence in India, with nine manufacturing facilities as of 2023. These facilities are integral to Amneal's global supply chain, producing a substantial portion of the company's product portfolio. The company's global operations are supported by a robust logistics infrastructure, ensuring timely and efficient delivery of products to markets worldwide.

3Industry Role

Amneal Pharmaceuticals LLC plays a multifaceted role in the United States pharmaceutical supply chain. As a vertically integrated company, it engages in the development, manufacturing, and distribution of pharmaceutical products, encompassing both generic and specialty medications. This integration allows Amneal to maintain control over the quality and cost of its products, ensuring they meet the standards required by healthcare providers and patients.

In addition to its manufacturing capabilities, Amneal's AvKARE segment serves as a distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets. This segment focuses on supplying essential medicines to various government agencies, including the Department of Defense and the Department of Veterans Affairs, thereby contributing to the accessibility and affordability of healthcare services.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Amneal Pharmaceuticals Llc NJ

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Amneal Pharmaceuticals LLC's sourcing strategy exhibits a high degree of concentration, with a significant portion of its pharmaceutical formulations imported from a single supplier in India: AMNEAL PHARMACEUTICALS PRIVATE LIMITED. Between 2022 and 2026, this supplier accounted for $2.4 million in imports, representing 100% of Amneal's pharmaceutical imports from India during this period.

This single-source dependency could pose risks related to supply chain disruptions, such as production delays, quality control issues, or geopolitical factors affecting trade relations. However, the exclusive relationship may also reflect a strategic choice to maintain consistency in product quality and supply reliability. The stability of this sourcing arrangement is crucial for Amneal's operations, and any changes in the supplier's performance or external factors could significantly impact Amneal's ability to meet market demand.

2Supply Chain Resilience

The resilience of Amneal Pharmaceuticals LLC's supply chain, particularly concerning its Indian supplier, is a critical factor in ensuring uninterrupted product availability. The company's reliance on a single supplier for its pharmaceutical imports from India suggests a need for robust contingency planning. While the exclusive relationship may offer benefits in terms of quality control and supply consistency, it also exposes Amneal to potential risks associated with supply chain disruptions.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the approval and monitoring of pharmaceutical products. The FDA ensures that drugs meet safety, efficacy, and quality standards before they can be marketed to the public. Key legislation governing pharmaceutical imports includes the Federal Food, Drug, and Cosmetic Act, which outlines the requirements for drug approval and importation.

For Indian generics to be marketed in the U.S., they must undergo the FDA's Abbreviated New Drug Application (ANDA) process. This pathway allows for the approval of generic drugs that are bioequivalent to their brand-name counterparts, facilitating market entry while maintaining therapeutic equivalence. The FDA's rigorous evaluation process ensures that imported generics meet the necessary standards for public health and safety.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the United States are stringent. Manufacturers and distributors must comply with FDA regulations, including obtaining appropriate approvals for each product intended for import. This process involves submitting detailed information about the product's composition, manufacturing process, and labeling to demonstrate compliance with FDA standards.

Amneal Pharmaceuticals Llc NJ — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Amneal Pharmaceuticals LLC's product strategy focuses on a diverse range of therapeutic areas, with a notable emphasis on advanced antibiotics, cardiovascular medications, and analgesics & antipyretics. Between 2022 and 2026, Amneal imported a total of $1.1 million worth of pharmaceutical formulations from India, encompassing four products across these three therapeutic categories.

The market demand for these therapeutic areas is driven by the prevalence of conditions such as infections, cardiovascular diseases, and pain management needs. By focusing on these segments, Amneal aims to address critical healthcare needs and provide accessible treatment options to patients. The company's strategic sourcing from India aligns with its objective to offer high-quality, cost-effective pharmaceutical products to the U.S. market.

TransData Nexus Research · DGFT trade data analysisMar 2026

Frequently Asked Questions — Amneal Pharmaceuticals Llc NJ

What products does Amneal Pharmaceuticals Llc NJ import from India?

Amneal Pharmaceuticals Llc NJ imports 4 pharmaceutical products across 3 categories. Top imports: Propranolol ($400.0K), Sulfamethoxazole ($250.0K), Tramadol ($250.0K), Trimethoprim ($250.0K).

Who supplies pharmaceuticals to Amneal Pharmaceuticals Llc NJ from India?

Amneal Pharmaceuticals Llc NJ sources from 1 verified Indian suppliers. The primary supplier is Amneal Pharmaceuticals Private Limited (100.0% of imports, $2.4M).

What is Amneal Pharmaceuticals Llc NJ's total pharmaceutical import value?

Amneal Pharmaceuticals Llc NJ's total pharmaceutical import value from India is $1.1M, based on 23 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Amneal Pharmaceuticals Llc NJ focus on?

Amneal Pharmaceuticals Llc NJ imports across 3 categories. The largest: Advanced Antibiotics (43.5%), Cardiovascular (34.8%), Analgesics & Antipyretics (21.7%).

Get Full Amneal Pharmaceuticals Llc NJ Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

Amneal Pharmaceuticals Llc NJ

Amneal Pharmaceuticals Llc NJ — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Amneal Pharmaceuticals Llc NJ?

What Formulations Does Amneal Pharmaceuticals Llc NJ Import?

What Products Does Amneal Pharmaceuticals Llc NJ Import?

Top Products by Import Value

Amneal Pharmaceuticals Llc NJ Therapeutic Categories — 3 Specializations